QIAGEN NV (QGEN)
48.57
+0.25
(+0.52%)
USD |
NYSE |
Feb 20, 16:00
48.63
+0.06
(+0.12%)
After-Hours: 20:00
QIAGEN Shareholders Equity (Quarterly) : 3.778B for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| InflaRx NV | 53.31M |
| CDT Equity, Inc. | 4.278M |
| LENZ Therapeutics, Inc. | 193.93M |
| Liminatus Pharma, Inc. | -1.646M |
| Oruka Therapeutics, Inc. | 486.79M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 6.296B |
| Total Liabilities (Quarterly) | 2.518B |
| Debt to Equity Ratio | 0.4379 |
| Current Ratio | 3.896 |
| Net Debt Paydown Yield | 0.57% |